Furthermore, our cohort of patients with IPF displayed an activated blood platelet signature consisting of CXCL4 concentrations correlating with increased active TGFβ1 concentrations, suggesting platelets may represent a cellular source of this profibrotic cytokine in the periphery of patients with IPF. This evidence concerns the gene PF4 and idiopathic pulmonary fibrosis.